Stock Events

Stock Events

Cytotools 

0
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-2,147.06%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
17,000Revenue
-365,000Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap251.94B
Amgen Inc. develops therapeutics in similar domains as bioXXmed, particularly in biotechnology and medical research.
Gilead Sciences
GILD
Mkt Cap211.7B
Gilead Sciences, Inc. operates in the biopharmaceutical field focusing on drugs that compete directly with bioXXmed's products.
Regeneron Pharmaceuticals
REGN
Mkt Cap95.99B
Regeneron Pharmaceuticals, Inc. is known for its innovative biopharmaceuticals that target the same diseases as bioXXmed.
Vertex Pharmaceuticals
VRTX
Mkt Cap141.65B
Vertex Pharmaceuticals Incorporated works on creating drugs for complex diseases, overlapping with bioXXmed's research areas.
Biogen
BIIB
Mkt Cap37.49B
Biogen Inc. focuses on neurological diseases and advanced biologics, competing in the same specialty areas as bioXXmed.
Incyte
INCY
Mkt Cap24.54B
Incyte Corporation deals with small molecule drugs for oncology and inflammation, areas also covered by bioXXmed.
Novo Nordisk
NVO
Mkt Cap176.43B
Novo Nordisk A/S is a global healthcare company that, while primarily focused on diabetes, also competes in other therapeutic areas covered by bioXXmed.

About

bioXXmed AG, an investment company, invests in biotechnology or medical technology companies with equity or debt capital. It engages in the development of products for the diagnosis, alleviation, or cure of diseases through investments. The company was formerly known as CytoTools AG and changed its name to bioXXmed AG in September 2022. The company was founded in 2000 and is based in Darmstadt, Germany.
Show More
CEO
Dr. Mark-André Freyberg
Employees
1
Country
Germany
ISIN
DE000A0KFRJ1
WKN
000A4BGGE

Listings

MU
DE
T5O.MU
F
DE
T5O.F

0 Comments

Share your thoughts

FAQs

What is Cytotools stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Cytotools stocks are traded under the ticker T5O.MU.
What is Cytotools revenue for the last year?▼
Cytotools revenue for the last year amounts to 17,000 EUR.
What is Cytotools net income for the last year?▼
T5O.MU net income for the last year is -365,000 EUR.
How many employees does Cytotools have?▼
As of November 2, 2026, the company has 1 employees.
In which sector is Cytotools located?▼
Cytotools operates in the Health & Wellness sector.
When did Cytotools complete a stock split?▼
Cytotools has not had any recent stock splits.
Where is Cytotools headquartered?▼
Cytotools is headquartered in Darmstadt, Germany.